LOCAL APPLICATION OF TRANEXAMIC ACID IN KNEE REPLACEMENT

Cover Page


Cite item

Abstract

The purpose of the study – assessment of the efficacy of local application of tranexamic acid in TKA and the choice of the optimal dosage. Materials and methods. 48 patients were included in open-prospective study and were randomized to one of four groups. In the first group tranexamic acid was used as intravenous bolus at the beginning of the operation at a dose of 15 mg/kg. Additionally, after the installation of the prosthetic components, the surgeon performed periarticular infiltration of soft tissue by tranexamic acid solution at a dose of 15 mg/kg. In the second group of patients tranexamic acid was used as 500 mg intravenous bolus before surgery, and 500 mg locally after installation of the prosthesis components. In the third group of patients received tranexamic acid once at the beginning of the operation at a dose of 15 mg/kg iv bolus. In the fourth group tranexam was used after surgery once at a dose of 10 mg/kg. Results. In the first group of patients were achieved statistically significant, 5-6 times, reduction of blood loss on drainage in comparison with other groups, where the volume of postoperative blood loss was not significantly different between groups. Also in the first group recorded the smallest decrease in hemoglobin at the 5th postoperative day compared to the third and fourth groups. Complications associated with the use of tranexamic acid were not revealed. Conclusion. The method of periarticular infiltration by tranexamic acid in combination with its intravenous use in knee joint replacement is an effective and safe method for reduction of post-operative blood loss.

About the authors

E. V. Pshenitsyna

Privolzhsky Federal Research Medical Centre
18, Verkhne-Volzhskaya nab., Nizhny Novgorod, 603155, Russia

Author for correspondence.
Email: Lenockaya90@rambler.ru
Junior Researcher of Anesthesiology and Intensive Care Department Russian Federation

V. I. Zagrekov

Privolzhsky Federal Research Medical Centre
18, Verkhne-Volzhskaya nab., Nizhny Novgorod, 603155, Russia

Email: Lenockaya90@rambler.ru
Dr. Sci. (Med), Head of Anesthesiology and Intensive Care Department Russian Federation

E. E. Malyshev

Privolzhsky Federal Research Medical Centre
18, Verkhne-Volzhskaya nab., Nizhny Novgorod, 603155, Russia
Novgorod State Medical Academy
10/1, pl. Minina i Pozharskogo, Nizhny Novgorod, 603155, Russia

Email: Lenockaya90@rambler.ru
Cand. Sci. (Med) Associate Professor of the Department of Traumatology, Orthopedics and Field Surgery, Nizhny Novgorod State Medical Academy; Orthopaedic Surgeon, Privolzhsky Federal Research Medical Centre Russian Federation

References

  1. Борисов Д.Б., Киров М.Ю. применение транексамовой кислоты при эндопротезировании крупных суставов. Новости хирургии. 2013;21(4):107-112.
  2. Загреков В.И. Центральные сегментарные блокады как метод сбережения крови при эндопротезировании тазобедренного сустава. Н. Новгород; 2010. 256 с.
  3. Зуев В.К., Азбаров А.А., Каргин А.Н. и др. Аутогемотрансфузия при эндопротезировании коленного и тазобедренного суставов с применением спинально-эпидуральной анестезии. В кн.: Бескровная хирургия – новые направления в хирургии, анестезиологии, трансфузиологии. М.; 2003. С. 209-214.
  4. Корнилов Н.В., Войтович А.В., Кустов В.М. и др. уменьшение кровопотери и переливание аутогенной крови при эндопротезировании крупных суставов. В кн.: проблемы бескровной хирургии. М.; 2001. С. 148-158.
  5. Кустов В.М., Корнилов Н.В. Медицинское обеспечение операций эндопротезирования крупных суставов. Спб.: Гиппократ; 2004. 344 с.
  6. Селиванов Д.Д., Сунгуров В.А., Лихванцев В.В. Конев Д.Е., Моисейкина Л.А. применение транексамовой кислоты при тотальном эндопротезировании тазобедренного сустава. Общая реаниматология. 2010;(6):62-65.
  7. Тихилов Р.М., Серебряков А.Б., Шубняков И.И., плиев Д.Г., Шильников В.А., Денисов А.О., Мясоедов А.А., Бояров А.А. Влияние различных факторов на кровопотерю при протезировании тазобедренного сустава. Травматология и ортопедия России. 2012;(3):5-11.
  8. Тихилов Р.М., Шубняков И.И., Моханна М.И., плиев Д.Г., Мясоедов А.А., Цыбин А.В., Амбросенков А.В., Близнюков В.В., Чиладзе И.Т., Шулепов Д.А. эффективность применения транексамовой кислоты для уменьшения кровопотери при эндопротезировании тазобедренного сустава. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2010;(1): 29-34.
  9. Шевченко Ю.Л., Стойко Ю.М., замятин М.Н. Теплых Б.А., Карпов И.А., Смолькин Д.А. Кровесберегающий эффект транексамовой кислоты при протезировании коленного сустава. Общая реаниматология. 2008;(6):21-25.
  10. Шевченко Ю.Л., Стойко Ю.М., Замятин М.Н.. Коррекция системы гемостаза при операциях эндопротезирования коленного сустава: Медицинская технология. М.; 2009. 19 с.
  11. Aggarwal A.К., Singh N., Sudesh P. Topical vs. Intravenous Tranexamic Acid in Reducing Blood Loss After Bilateral Total Knee Arthroplasty: A Prospective Study. J Arthroplasty. 2016;31(7):1442-1448. doi: 10.1016/j.arth.2015.12.033.
  12. Brecher M.E., Monk T., goodnough L.T. A standardized method for calculating blood loss. Transfusion. 1997;37(10):1070-1074.
  13. Carling М.S., Jeppsson А, Eriksson B. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J orthop Surg res. 2015; 10: 48. doi: 10.1186/s13018-015-0188-6.
  14. Ellis M.H., fredman B., Zohar E. et al. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth. 2001;13(7): 509-513.
  15. Irisson E. et al. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. orthop Traumatol Surg res. 2012; 98(5): 477-483. doi: 10.1016/j.otsr.2012.05.002.
  16. Jain N.P., Nisthane P.P., Shah N.A. Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplasty. 2016; 31(2): 542-547. doi: 10.1016/j.arth.2015.09.029.
  17. Keyhani S., Esmailiejah А.А., Abbasian M. et al. Which route of tranexamic acid administration is more effective to reduce blood loss following total knee arthroplasty? Arch Bone Joint Surg. 2016; 4(1):65-69.
  18. Lemaire R. Strategies for blood management in orthopedic and trauma surgery. J Bone Joint Surg. Br. 2008; 90B(9): 1128-1136. doi: 10.1302/0301-620x.90B9.21115.
  19. Macgillivray R.g. et al. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty. 2011; 26(1): 24-28. doi: 10.1016/j.arth.2009.11.013.
  20. Mahdy M., Webster N.R. Perioperative systemic haemostatic agents. Br J Anaesth. 2004; 93(6):842-858. doi: 10.1093/bja/aeh227.
  21. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;(30): 270-382. doi: 10.1097/EJA.0b013e32835f4d5b.
  22. Maniar R.N. et al. Most Effective Regimen of Tranexamic Acid in Knee Arthroplasty: A Prospective Randomized Controlled Study in 240 Patients. Clin orthop relat res. 2012;470(9):2605-2612. doi: 10.1007/s11999-012-2310-y.
  23. Molloy D.O., Archbold H.A.P., Ogonda L. et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement. J Bone Joint Surg Br. 2008;89-B(3):306-309. doi: 10.1302/0301-620x.89B3.17565.
  24. Pinsornsak P., Rojanavijitku S., Chumchuen S. Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial. BMC Musculoskelet Disord. 2016;17:313. doi: 10.1186/s12891-016-1176-7.
  25. Ralley f.E., Berta D., Binns V. et al. One intraoperative dose of tranexamic аcid for patients having primary hip or knee arthroplasty. Clin orthop relat res. 2010;468(7):1905-1911. doi: 10.1007/s11999-009-1217-8.
  26. Sepah y.J. et al. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee re-112 placement. J orthop Surg res. 2011; (6):22. doi: 10.1186/1749-799x-6-22.
  27. Shin y., yoon J., Lee H. et al. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2016. doi: 10.1007/s00167-016-4235-6.
  28. Slappendel R., Dirksen R., Weber E.W., van der Schaaf D.B. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta orthop Scand. 2003;74(5):569-575.
  29. doi: 10.1080/00016470310017974.
  30. Tzatzairis T.K., Drosos g.I., Kotsios S.E. et al. Intravenous vs. Topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study. J Arthroplasty. 2016;31(11):2465-2470. doi: 10.1016/j.arth.2016.04.036.
  31. Uğurlu M., Aksekili M.A., Çağlar C. et al. Effect of topical and intravenously applied tranexamic acid compared to control group on bleeding in primary unilateral total knee arthroplasty. J Knee Surg. 2016 [Epub ahead of print]. doi: 10.1055/s-0036-1583270.
  32. Wang g., Wang D., Wang B. et al. Efficacy and safety evaluation of intraarticular injection of tranexamic acid in total knee arthroplasty operation with temporarily drainage close. Int J Clin Exp Med. 2015;8(8):14328-14334.

Copyright (c) 2016



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies